4//SEC Filing
OSHEA WILLIAM J 4
Accession 0001181431-13-014212
CIK 0001401923other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:47 PM ET
Size
5.6 KB
Accession
0001181431-13-014212
Insider Transaction Report
Form 4
OSHEA WILLIAM J
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2013-03-01−20,000→ 0 totalExercise: $13.79Exp: 2022-01-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms described in the Offer to Purchase for Cash filed with the Securities and Exchange Commission on January 31, 2013 and the Agreement and Plan of Merger, dated as of January 22, 2013, by and among Allergan, Inc., Groundhog Acquisition, Inc. and MAP Pharmaceuticals, Inc. (the "Issuer"), these options to purchase shares of common stock of the Issuer (the "Common Stock"), which became fully vested on March 1, 2013 (the "Effective Time"), were canceled at the Effective Time in exchange for a cash payment of $224,200.00, representing the number of shares of the Common Stock underlying such options multiplied by $25.00, less the aggregate price of the options as exercised.
Documents
Issuer
MAP Pharmaceuticals, Inc.
CIK 0001401923
Entity typeother
Related Parties
1- filerCIK 0001251725
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:47 PM ET
- Size
- 5.6 KB